Catalyst Wire Dossier Catalyst Wire Dossier

casein phosphopeptide-amorphous calcium phosphate

casein phosphopeptide-amorphous calcium phosphate · Fujian Medical University
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for casein phosphopeptide-amorphous calcium phosphate, covering 2018-02-08 to 2020-03-11. Get the full timeline:

Most recent: Clinical Trial Update: The Effect of Casein Phosphopeptide Amorphous Calcium Phosphate on Affected Dentine [Phase 2]

See pricing